​Dr. Mark Egerton has more than 20 years' patent experience specialising in cell and molecular biology, protein chemistry, immunology, biochemistry, genomics and medical devices. Mark's scientific experience includes a PhD in T cell immunology and post-doctoral research in the fields of immunology and signal transduction at the National Institutes of Health (USA) and at the Queensland Institute of Medical Research.
​
Mark is committed to working with clients such as universities and startup companies to protect inventions in Australia and major foreign jurisdictions such as Europe, the USA, Japan and China. Mark brings a sound understanding of patent strategy to his role, particularly with regard to the complexities of patenting biotechnological inventions, where there are significant differences in law practice across different jurisdictions. Mark's expertise and experience are highly prized by domestic and international businesses, universities and research institutes that are engaged in developing biotechnology inventions.
​
Mark commenced his patent attorney career at Fisher Adams Kelly (now Spruson & Ferguson) in 1996 and became a partner there in 2001. Mark joined Davis IP in 2020.
QUALIFICATIONS
-
B.Sc (Hons) – University of Melbourne (Walter & Eliza Hall Institute).
-
PhD – University of Melbourne (Walter & Eliza Hall Institute).
-
Registered Australian and New Zealand Patent Attorney
​
​
PROFESSIONAL MEMBERSHIP
-
Fellow of the Institute of Patent and Trademark Attorneys